Search research articles
Contact Us
Filters
Showing results (951-960 of 964) with videos related to
Page
of 97
Sort By:
Journal of the American Academy of Dermatology
|
May 13, 2014
Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies
Lawrence F Eichenfield, Wynnis L Tom, Timothy G Berger, et al.
Journal of the American Academy of Dermatology
|
September 30, 2014
Guidelines of care for the management of atopic dermatitis: Section 4. Prevention of disease flares and use of adjunctive therapies and approaches
Robert Sidbury, Wynnis L Tom, James N Bergman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 12, 2024
European Stop Tyrosine Kinase Inhibitor Trial (EURO-SKI) in Chronic Myeloid Leukemia: Final Analysis and Novel Prognostic Factors for Treatment-Free Remission
Francois-Xavier Mahon, Markus Pfirrmann, Stéphanie Dulucq, et al.
Journal of the American Academy of Dermatology
|
December 3, 2013
Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis
Lawrence F Eichenfield, Wynnis L Tom, Sarah L Chamlin, et al.
Journal of Internal Medicine
|
February 28, 2026
Increased intervals in enzyme replacement therapy for stable type 1 Gaucher disease: A non-inferiority sequential trial emulation
Maxime Beydon, Jérôme Stirnemann, Karima Yousfi, et al.
Journal of Inherited Metabolic Disease
|
May 10, 2025
Epidemiology of Gaucher Disease in France: Trends in Incidence, Mortality, Management, and Complications Over Three Decades
Yann Nguyen, Maxime Beydon, Karima Yousfi, et al.
Haematologica
|
May 26, 2022
Kinetics of early and late molecular recurrences after first-line imatinib cessation in chronic myeloid leukemia: updated results from the STIM2 trial
Stéphanie Dulucq, Franck E Nicolini, Delphine Rea, et al.
Blood Cells, Molecules & Diseases
|
March 10, 2017
Management goals for type 1 Gaucher disease: An expert consensus document from the European working group on Gaucher disease
M Biegstraaten, T M Cox, N Belmatoug, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 12, 2019
Evaluation of Residual Disease and TKI Duration Are Critical Predictive Factors for Molecular Recurrence after Stopping Imatinib First-line in Chronic Phase CML Patients
Franck Emmanuel Nicolini, Stéphanie Dulucq, Lisa Boureau, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
September 11, 2012
AAD/ACMS/ASDSA/ASMS 2012 appropriate use criteria for Mohs micrographic surgery: a report of the American Academy of Dermatology, American College of Mohs Surgery, American Society for Dermatologic Surgery Association, and the American Society for Mohs Surgery
, , , et al.
Page
of 97
Search research articles
Search
Showing results (951-960 of 964) with videos related to
Sort By:
Page
of 97
Journal of the American Academy of Dermatology
|
May 13, 2014
Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies
Lawrence F Eichenfield, Wynnis L Tom, Timothy G Berger, et al.
Journal of the American Academy of Dermatology
|
September 30, 2014
Guidelines of care for the management of atopic dermatitis: Section 4. Prevention of disease flares and use of adjunctive therapies and approaches
Robert Sidbury, Wynnis L Tom, James N Bergman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 12, 2024
European Stop Tyrosine Kinase Inhibitor Trial (EURO-SKI) in Chronic Myeloid Leukemia: Final Analysis and Novel Prognostic Factors for Treatment-Free Remission
Francois-Xavier Mahon, Markus Pfirrmann, Stéphanie Dulucq, et al.
Journal of the American Academy of Dermatology
|
December 3, 2013
Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis
Lawrence F Eichenfield, Wynnis L Tom, Sarah L Chamlin, et al.
Journal of Internal Medicine
|
February 28, 2026
Increased intervals in enzyme replacement therapy for stable type 1 Gaucher disease: A non-inferiority sequential trial emulation
Maxime Beydon, Jérôme Stirnemann, Karima Yousfi, et al.
Journal of Inherited Metabolic Disease
|
May 10, 2025
Epidemiology of Gaucher Disease in France: Trends in Incidence, Mortality, Management, and Complications Over Three Decades
Yann Nguyen, Maxime Beydon, Karima Yousfi, et al.
Haematologica
|
May 26, 2022
Kinetics of early and late molecular recurrences after first-line imatinib cessation in chronic myeloid leukemia: updated results from the STIM2 trial
Stéphanie Dulucq, Franck E Nicolini, Delphine Rea, et al.
Blood Cells, Molecules & Diseases
|
March 10, 2017
Management goals for type 1 Gaucher disease: An expert consensus document from the European working group on Gaucher disease
M Biegstraaten, T M Cox, N Belmatoug, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 12, 2019
Evaluation of Residual Disease and TKI Duration Are Critical Predictive Factors for Molecular Recurrence after Stopping Imatinib First-line in Chronic Phase CML Patients
Franck Emmanuel Nicolini, Stéphanie Dulucq, Lisa Boureau, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
September 11, 2012
AAD/ACMS/ASDSA/ASMS 2012 appropriate use criteria for Mohs micrographic surgery: a report of the American Academy of Dermatology, American College of Mohs Surgery, American Society for Dermatologic Surgery Association, and the American Society for Mohs Surgery
, , , et al.
Page
of 97